Kapka T. Miteva (Switzerland)

University of Geneva Division of Cardiology
Dr. Kapka Miteva, expert in the field of cardiovascular research, in particular to mechanisms of inflammation and its regulation in cardiovascular diseases and atherosclerosis. After obtaining her master degree in Molecular Medicine at Charité – University Medical School, Berlin, Germany, Dr. Miteva pursued her initial research activities in the group of cardiovascular repair of Prof. Carsten Tschöpe in Charité, Berlin, Germany, where she received her PhD. In June 2018, Dr. Kapka Miteva joined the laboratory of cardiology of Prof. François Mach at the Faculty of Medicine, University of Geneva, Switzerland as an research and teaching fellow working on development and progression of atherosclerosis.

Author Of 1 Presentation

O065 - Single-Cell Analysis Uncovers Osteoblast Factor GDF10 as Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation Associated with Plaque Rupture in Human Carotid Artery Disease (ID 665)

Session Type
Vascular Biology
Session Time
10:30 - 12:00
Date
Wed, 02.06.2021
Room
Live Streamed
Lecture Time
11:03 - 11:11

Abstract

Background and Aims

Vascular smooth muscle cells (VSMC) are not terminally differentiated and undergo complex phenotypic changes during atherosclerosis. However, the complex heterogeneity of VSMC and how VSMC de-differentiation affects human carotid artery disease (CAD) risk has not been clearly established. The aim of the present study is to comprehensively characterized the transcriptomic profile of phenotypically modulated VSMC and to identify mediators of VSMC transition to osteogenic like cells with likely detrimental role for atherosclerosis plaque stability.

Methods

Single-cell RNA sequencing of CD45 negative cells derived from Apoe-/- mice on a normal (NCD) or high cholesterol diet (HCD) was performed. To confirm the identified marker mediator of VSMC transition to osteogenic like cells, immunofluorescence staining of aortic roots of VSMC lineage tracing Apoe-/- Myh11-CreERT2, ROSA26 STOP-flox eYFP+/+ mice fed an NCD or HCD and of internal carotid plaque specimens from symptomatic and asymptomatic patients with CAD was used. VSMC osteogenic switch was quantified upon GDF10 and oxLDL stimulation by flow cytometry.

Results

Disease-relevant gene signature of VSMC macrophagic calcific phenotype, VSMC mesenchymal chondrogenic phenotype, VSMC inflammatory and fibro phenotype and VSMC inflammatory phenotype was revealed. The osteoblast factor GDF10 was highly expressed in phenotypically modified VSMC clusters, in parallel GDF10 stimulation in combination with oxLDL triggered VSMC osteogenic switch in vitro. Moreover, higher GDF10 expression in phenotypically modified VSMC in human atherosclerotic plaques was associated with an increased risk of plaque rupture in CAD patients.

Conclusions

Osteoblast factor GDF10 is associated with VSMC transition to osteogenic like cells with likely detrimental role in atherosclerosis plaque stability.

Hide

Presenter of 1 Presentation

O065 - Single-Cell Analysis Uncovers Osteoblast Factor GDF10 as Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation Associated with Plaque Rupture in Human Carotid Artery Disease (ID 665)

Session Type
Vascular Biology
Session Time
10:30 - 12:00
Date
Wed, 02.06.2021
Room
Live Streamed
Lecture Time
11:03 - 11:11

Abstract

Background and Aims

Vascular smooth muscle cells (VSMC) are not terminally differentiated and undergo complex phenotypic changes during atherosclerosis. However, the complex heterogeneity of VSMC and how VSMC de-differentiation affects human carotid artery disease (CAD) risk has not been clearly established. The aim of the present study is to comprehensively characterized the transcriptomic profile of phenotypically modulated VSMC and to identify mediators of VSMC transition to osteogenic like cells with likely detrimental role for atherosclerosis plaque stability.

Methods

Single-cell RNA sequencing of CD45 negative cells derived from Apoe-/- mice on a normal (NCD) or high cholesterol diet (HCD) was performed. To confirm the identified marker mediator of VSMC transition to osteogenic like cells, immunofluorescence staining of aortic roots of VSMC lineage tracing Apoe-/- Myh11-CreERT2, ROSA26 STOP-flox eYFP+/+ mice fed an NCD or HCD and of internal carotid plaque specimens from symptomatic and asymptomatic patients with CAD was used. VSMC osteogenic switch was quantified upon GDF10 and oxLDL stimulation by flow cytometry.

Results

Disease-relevant gene signature of VSMC macrophagic calcific phenotype, VSMC mesenchymal chondrogenic phenotype, VSMC inflammatory and fibro phenotype and VSMC inflammatory phenotype was revealed. The osteoblast factor GDF10 was highly expressed in phenotypically modified VSMC clusters, in parallel GDF10 stimulation in combination with oxLDL triggered VSMC osteogenic switch in vitro. Moreover, higher GDF10 expression in phenotypically modified VSMC in human atherosclerotic plaques was associated with an increased risk of plaque rupture in CAD patients.

Conclusions

Osteoblast factor GDF10 is associated with VSMC transition to osteogenic like cells with likely detrimental role in atherosclerosis plaque stability.

Hide